fbpx

Advanced Colorectal Cancer

Carcinoma of Sigmoid Colon

Female, 62 years

Patient Internal ID: 627298751

ICD-10 code

C18.7 Malignant Neoplasm of Sigmoid Colon

Diagnosis (Incl. Metastases/Stage) and Year

June 2017
Colon Sigmoid Carcinoma G2 pT3N2M1b (3/9) Lymph Node Vascular Invasion, Metastasis of the Left Lung Lower Lobe.

Previous Treatment

Surgery, Dendritic Cell Vaccine Therapy (DC), Oncolytic Virotherapy (NDV), Immunotherapy (Pembrolizumab), Immunogen Cell Death Therapy Chemotherapy (ICD), Modulated Loco-Regional Radiofrequency Hyperthermia (mEHT), Oncolytic Virotherapy (NDV), Dendritic Cell Vaccine Therapy (DC), Surgery (Resection of Lung Segment).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of approximately 32 months from diagnosis.

Treatment Provided

Autologous DCV (18 doses) over a period of 18 months.

Patient Survival/Condition and Year
Date of Review: 18/11/2023

The patient has survived for 6 and a half years and has a stable disease. It can be concluded that the addition of Immunotherapy, alongside Surgery, DC-vaccine, Immunotherapy, ICD, mEHT and NDV, has extended patient survival by an estimated 45 months so far.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok